Julia Lipovetzki

GRP78 expression in peripheral blood mononuclear cells is a new predictive marker for the benefit of taxanes in breast cancer neoadjuvant treatment

R. Yerushalmi, A. Raiter, I. Lubin, 2020, BMC Cancer.

GRP78 expression in peripheral blood mononuclear cells is a new predictive marker for the benefit of taxanes in breast cancer neoadjuvant treatment

R. Yerushalmi, A. Raiter, I. Lubin, 2020, BMC Cancer.